Your browser doesn't support javascript.
loading
Will Daratumumab be the next game changer in early thymic precursor-acute lymphoblastic leukaemia?
Mirgh, Sumeet; Ahmed, Rayaz; Agrawal, Narendra; Khushoo, Vishvdeep; Garg, Ambar; Francis, Shinto; Tejwani, Narender; Singh, Neha; Bhurani, Dinesh.
Afiliação
  • Mirgh S; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Ahmed R; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Agrawal N; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Khushoo V; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Garg A; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Francis S; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Tejwani N; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Singh N; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Bhurani D; Department of Haematology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Br J Haematol ; 187(2): e33-e35, 2019 10.
Article em En | MEDLINE | ID: mdl-31452197

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Anticorpos Monoclonais Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Anticorpos Monoclonais Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article